Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.46B 1.27B 1.18B 1.08B 2.05B 141B 2.09B 14.01B 5.5B 68.67B 5.49B 5.37B 237B P/E 2026 *
28.9x
P/E 2027 * 15.7x
Enterprise Value 2.8B 2.44B 2.25B 2.07B 3.93B 269B 4B 26.84B 10.54B 132B 10.51B 10.28B 454B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.52x
Free-Float
72.36%
Yield 2026 *
-
Yield 2027 * -
1 day+2.07%
1 week+7.56%
Current month+4.57%
1 month+5.68%
3 months+69.80%
6 months+49.88%
Current year+51.21%
1 week 17.01
Extreme 17.01
19.13
1 month 17.01
Extreme 17.01
19.13
Current year 8.7
Extreme 8.7
19.13
1 year 8.7
Extreme 8.7
19.13
3 years 8.7
Extreme 8.7
46.75
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
03/07Tax

Chief Financial Officer

-5,226 0.0067%
01/07Tax

Controller/Auditor

-937 0.0012%
01/07Free

Executive/Senior Manager

11,180 0.0144%
Change 5-day change 1-year change 3-year change Capi.($)
+2.07%+7.56%+53.81%-56.28% 1.43B
+1.06%-6.86%-32.39%-17.29% 155B
+1.48%-4.01%-10.32%-8.19% 102B
-1.89%-2.60%-0.16%+54.93% 58.81B
-0.94%-1.23%+39.41%+54.08% 52.82B
+2.81%-0.91%-12.54%-40.29% 41.51B
+2.02%-8.30% - - 32.69B
-1.88%-1.14%-14.77%-47.04% 28.6B
+0.38%+0.82%+59.92%-6.78% 25.27B
+1.31%-1.82%-6.35%-7.69% 20.34B
Average +0.86%-2.38%+8.51%-8.28% 51.79B
Weighted average by Cap. +0.53%-4.29%-7.16%-1.75%

Financials

2026 *2027 *
Net sales 1.68B 1.46B 1.35B 1.24B 2.35B 161B 2.39B 16.07B 6.31B 78.77B 6.29B 6.16B 272B 1.73B 1.51B 1.39B 1.28B 2.43B 167B 2.47B 16.59B 6.51B 81.31B 6.5B 6.35B 280B
Net income 42.73M 37.26M 34.39M 31.56M 59.96M 4.11B 60.99M 410M 161M 2.01B 160M 157M 6.93B 74.56M 65.02M 60.01M 55.07M 105M 7.18B 106M 715M 281M 3.5B 280M 274M 12.08B
Net Debt 1.34B 1.17B 1.08B 988M 1.88B 129B 1.91B 12.83B 5.04B 62.9B 5.03B 4.92B 217B 1.18B 1.03B 946M 869M 1.65B 113B 1.68B 11.28B 4.43B 55.27B 4.42B 4.32B 191B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
15/07/26 USD 18.78 +2.07% 771,962
14/07/26 USD 18.40 -0.97% 1,070,166
13/07/26 USD 18.58 -1.12% 803,323
10/07/26 USD 18.79 +2.18% 951,869
09/07/26 USD 18.39 +6.30% 939,773
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
18.78USD
Average target price
18.00USD
Spread / Average Target
-4.15%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock